Trellus Health plc (AIM:TRLS)
London · Delayed Price · Currency is GBP · Price in GBX 0.1200
0.00 (0.00%)
Aug 25, 2026, 11:01 AM GMT
Trellus Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 1.57 | 4.34 | 12.17 | 19.09 | 31.98 | 3.68 |
Cash & Short-Term Investments | 1.57 | 4.34 | 12.17 | 19.09 | 31.98 | 3.68 |
Cash Growth | -80.51% | -64.29% | -36.25% | -40.33% | 768.13% | - |
Accounts Receivable | 0.29 | 0.06 | - | - | 0.03 | - |
Other Receivables | - | 0.02 | 0.01 | - | 0.1 | - |
Receivables | 0.29 | 0.08 | 0.01 | - | 0.12 | - |
Prepaid Expenses | - | 0.09 | 0.15 | 0.28 | 0.33 | 0.01 |
Total Current Assets | 1.86 | 4.51 | 12.33 | 19.37 | 32.43 | 3.7 |
Property, Plant & Equipment | 0.01 | 0.01 | 0.04 | 0.06 | 0.08 | 0.01 |
Other Intangible Assets | 7.35 | 7.62 | 7.92 | 6.49 | 4.28 | 0.66 |
Total Assets | 9.22 | 12.14 | 20.29 | 25.91 | 36.8 | 4.37 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 0.51 | 0.11 | 0.5 | 0.46 | 0.93 | 0.07 |
Accrued Expenses | - | 0.26 | 0.29 | 0.36 | 0.59 | 0.05 |
Total Current Liabilities | 0.51 | 0.37 | 0.79 | 0.82 | 1.52 | 0.12 |
Total Liabilities | 0.51 | 0.37 | 0.79 | 0.82 | 1.52 | 0.12 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.01 |
Additional Paid-In Capital | 43.39 | 43.39 | 43.39 | 43.39 | 43.39 | 5 |
Retained Earnings | -32.59 | -29.6 | -21.81 | -15.47 | -6.66 | -0.76 |
Comprehensive Income & Other | -2.23 | -2.16 | -2.21 | -2.96 | -1.59 | - |
Shareholders' Equity | 8.71 | 11.77 | 19.5 | 25.09 | 35.27 | 4.25 |
Total Liabilities & Equity | 9.22 | 12.14 | 20.29 | 25.91 | 36.8 | 4.37 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Cash (Debt) | 1.57 | 4.34 | 12.17 | 19.09 | 31.98 | 3.68 |
Net Cash Growth | -80.51% | -64.29% | -36.25% | -40.33% | 768.13% | - |
Net Cash Per Share | 0.01 | 0.03 | 0.08 | 0.12 | 0.24 | 0.04 |
Filing Date Shares Outstanding | 161.51 | 161.51 | 161.51 | 161.51 | 161.51 | 84.04 |
Total Common Shares Outstanding | 161.51 | 161.51 | 161.51 | 161.51 | 161.51 | 84.04 |
Working Capital | 1.35 | 4.14 | 11.54 | 18.55 | 30.91 | 3.57 |
Book Value Per Share | 0.05 | 0.07 | 0.12 | 0.16 | 0.22 | 0.05 |
Tangible Book Value | 1.36 | 4.15 | 11.58 | 18.6 | 30.99 | 3.58 |
Tangible Book Value Per Share | 0.01 | 0.03 | 0.07 | 0.12 | 0.19 | 0.04 |
Machinery | - | - | - | - | - | 0.01 |